Advertisement

Management of Immunosuppressed Patient with HIV and Hepatitis B and Brain Tumor

  • Rakhi Pal
  • Anand Rajan
Chapter
  • 28 Downloads

Abstract

Important insights have been gained into the pathogenesis of human immunodeficiency virus (HIV) infections and hepatitis B infections, but managing these patients still remains challenging. Anesthesiologists should be aware of the implications of dealing with increasing numbers of both diagnosed and undiagnosed, symptomatic and asymptomatic HIV-infected patients in the operating room.

References

  1. 1.
    Boise L, Gill MJ, Power C. HIV infection of the central nervous system: clinical features and neuropathogenesis. Neurol Clin. 2008;26:799–819.CrossRefGoogle Scholar
  2. 2.
    Weller I. Williams I. ABC of AIDS. BMJ. 2001;June 9;322Google Scholar
  3. 3.
    Wynn G, Zapor M, Smith B, et al. Antiretrovirals part 1: overview, history and focus on protease inhibitors. Psychosomatics. 2004;45:262–70.CrossRefGoogle Scholar
  4. 4.
    Avidan MS, Jones N, Pozniak AL. Anaesthesia. 2000;55:344–54.CrossRefGoogle Scholar
  5. 5.
    Dasgupta A, Okhuysen P. Pharmacokinetic and other drug interactions in patients with AIDS. Ther Drug Monit. 2001;23:591–605.CrossRefGoogle Scholar
  6. 6.
    Foisy M, Tseng A. Interactions between sedatives/hypnotics and protease inhibitors/NNRTIs. www.tthhivclinic.com 2002; September 20: 1–7.
  7. 7.
    Rainey P. HIV drug interactions: the good, the bad and the other. Ther Drug Monit. 2002;24(1):26–31.CrossRefGoogle Scholar
  8. 8.
    Penfold J, Clark AJ. Pain syndromes in HIV infection. Can J Anaesth. 1992;39:724–30.CrossRefGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2020

Authors and Affiliations

  • Rakhi Pal
    • 1
  • Anand Rajan
    • 2
  1. 1.University HospitalsClevelandUSA
  2. 2.Ohio State UniversityColumbusUSA

Personalised recommendations